US Stock MarketDetailed Quotes

RVMD Revolution Medicines

Watchlist
  • 44.170
  • +0.310+0.71%
Close Sep 27 16:00 ET
  • 43.930
  • -0.240-0.54%
Post 20:01 ET
7.38BMarket Cap-11873P/E (TTM)

Revolution Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Revolution Medicines Q2 2024 Earnings Date

Currency：USDAug 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
807.69K
0
-807.69K
Miss Est.
-78.88%
-100.00%
-100.00%
EPS
-0.78
-0.81
-0.03
Miss Est.
+15.30%
+11.96%
-3.95%
Analyst Rating
Strong Buy

Sep 27, 2024

Revolution Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 807.690K--
--2024/Q3-- / 807.690K--
Aug 7, 20242024/Q20.000 / 807.690K--
May 8, 20242024/Q10.000 / 674.200K--
Feb 26, 20242023/Q4742.000K / 1.200M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 807.690K--
--2024/Q3-- / 807.690K--
Aug 7, 20242024/Q20.000 / 807.690K--
May 8, 20242024/Q10.000 / 674.200K--
Feb 26, 20242023/Q4742.000K / 1.200M--

Unlock Free Earnings Estimates

Revolution Medicines Earnings Reports

  • 10-Q: Q2 2024 Earnings Report

    Aug 7 16:18 ET

  • 10-Q: Q1 2024 Earnings Report

    May 8 16:19 ET

  • Revolution Medicines | 10-K: FY2023 Annual Report

    Feb 26 22:23 ET

  • Revolution Medicines | 10-Q: Q3 2023 Earnings Report

    Nov 6, 2023 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 27, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data